Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 2
2012 1
2015 2
2016 1
2017 4
2018 8
2019 14
2020 7
2021 13
2022 6
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study.
Pires da Silva I, Ahmed T, Reijers ILM, Weppler AM, Betof Warner A, Patrinely JR, Serra-Bellver P, Allayous C, Mangana J, Nguyen K, Zimmer L, Trojaniello C, Stout D, Lyle M, Klein O, Gerard CL, Michielin O, Haydon A, Ascierto PA, Carlino MS, Lebbe C, Lorigan P, Johnson DB, Sandhu S, Lo SN, Blank CU, Menzies AM, Long GV. Pires da Silva I, et al. Among authors: mangana j. Lancet Oncol. 2021 Jun;22(6):836-847. doi: 10.1016/S1470-2045(21)00097-8. Epub 2021 May 11. Lancet Oncol. 2021. PMID: 33989557
Sorafenib in melanoma.
Mangana J, Levesque MP, Karpova MB, Dummer R. Mangana J, et al. Expert Opin Investig Drugs. 2012 Apr;21(4):557-68. doi: 10.1517/13543784.2012.665872. Epub 2012 Mar 7. Expert Opin Investig Drugs. 2012. PMID: 22394203 Review.
How I treat metastatic melanoma.
Dummer R, Mangana J, Frauchiger AL, Lang C, Micaletto S, Barysch MJ. Dummer R, et al. Among authors: mangana j. ESMO Open. 2019 Jul 21;4(Suppl 2):e000509. doi: 10.1136/esmoopen-2019-000509. eCollection 2019. ESMO Open. 2019. PMID: 31423341 Free PMC article. Review.
Update on adjuvant melanoma therapy.
Dimitriou F, Braun RP, Mangana J. Dimitriou F, et al. Among authors: mangana j. Curr Opin Oncol. 2018 Mar;30(2):118-124. doi: 10.1097/CCO.0000000000000432. Curr Opin Oncol. 2018. PMID: 29256902 Free article. Review.
Targeting complex, adaptive responses in melanoma therapy.
Cheng P, Levesque MP, Dummer R, Mangana J. Cheng P, et al. Among authors: mangana j. Cancer Treat Rev. 2020 Jun;86:101997. doi: 10.1016/j.ctrv.2020.101997. Epub 2020 Mar 2. Cancer Treat Rev. 2020. PMID: 32179238 Review.
Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma.
Bhave P, Ahmed T, Lo SN, Shoushtari A, Zaremba A, Versluis JM, Mangana J, Weichenthal M, Si L, Lesimple T, Robert C, Trojanello C, Wicky A, Heywood R, Tran L, Batty K, Dimitriou F, Stansfeld A, Allayous C, Schwarze JK, Mooradian MJ, Klein O, Mehmi I, Roberts-Thomson R, Maurichi A, Yeoh HL, Khattak A, Zimmer L, Blank CU, Ramelyte E, Kähler KC, Roy S, Ascierto PA, Michielin O, Lorigan PC, Johnson DB, Plummer R, Lebbe C, Neyns B, Sullivan R, Hamid O, Santinami M, McArthur GA, Haydon AM, Long GV, Menzies AM, Carlino MS. Bhave P, et al. Among authors: mangana j. J Immunother Cancer. 2022 Jul;10(7):e004668. doi: 10.1136/jitc-2022-004668. J Immunother Cancer. 2022. PMID: 35793872 Free PMC article.
EGFR expression is associated with relapse in a melanoma cohort receiving adjuvant PD-1-based immunotherapy.
Amaral T, Pop OT, Chatziioannou E, Sinnberg T, Niessner H, Zhao J, Ring SS, Joerger M, Schroeder C, Armeanu-Ebinger S, Cozzio A, Leiter U, Thomas I, Jochum W, Garbe C, Forchhammer S, Levesque M, Mangana J, Hölzel M, Dummer R, Schürch CM, Forschner A, Flatz L. Amaral T, et al. Among authors: mangana j. J Am Acad Dermatol. 2023 Nov;89(5):1072-1074. doi: 10.1016/j.jaad.2023.06.057. Epub 2023 Jul 22. J Am Acad Dermatol. 2023. PMID: 37487833 No abstract available.
Serum S100B Levels in Melanoma.
Frauchiger AL, Dummer R, Mangana J. Frauchiger AL, et al. Among authors: mangana j. Methods Mol Biol. 2019;1929:691-700. doi: 10.1007/978-1-4939-9030-6_43. Methods Mol Biol. 2019. PMID: 30710305
A new B-Raf inhibitor combo for advanced melanoma.
Barysch MJ, Mangana J, Dummer R. Barysch MJ, et al. Among authors: mangana j. Oncotarget. 2018 Oct 2;9(77):34457-34458. doi: 10.18632/oncotarget.26171. eCollection 2018 Oct 2. Oncotarget. 2018. PMID: 30349640 Free PMC article. No abstract available.
The features and management of acquired resistance to PD1-based therapy in metastatic melanoma.
Hepner A, Versluis JM, Wallace R, Allayous C, Brown LJ, Trojaniello C, Gerard CL, Jansen YJ, Bhave P, Neyns B, Haydon A, Michielin O, Mangana J, Klein O, Shoushtari AN, Warner AB, Ascierto PA, McQuade JL, Carlino MS, Zimmer L, Lebbe C, Johnson DB, Sandhu S, Atkinson V, Blank CU, Lo SN, Long GV, Menzies AM. Hepner A, et al. Among authors: mangana j. Eur J Cancer. 2024 Jan;196:113441. doi: 10.1016/j.ejca.2023.113441. Epub 2023 Nov 20. Eur J Cancer. 2024. PMID: 37988842
68 results